These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 9174197)
1. Modified agar dilution susceptibility testing method for determining in vitro activities of antifungal agents, including azole compounds. Yoshida T; Jono K; Okonogi K Antimicrob Agents Chemother; 1997 Jun; 41(6):1349-51. PubMed ID: 9174197 [TBL] [Abstract][Full Text] [Related]
2. In vitro antifungal synergy between amphiphilic aminoglycoside K20 and azoles against Candida species and Cryptococcus neoformans. Shrestha SK; Grilley M; Anderson T; Dhiman C; Oblad J; Chang CW; Sorensen KN; Takemoto JY Med Mycol; 2015 Nov; 53(8):837-44. PubMed ID: 26260746 [TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of National Committee for Clinical Laboratory Standards broth macrodilution and agar dilution screening methods for testing fluconazole susceptibility of Cryptococcus neoformans. Kirkpatrick WR; McAtee RK; Revankar SG; Fothergill AW; McCarthy DI; Rinaldi MG; Patterson TF J Clin Microbiol; 1998 May; 36(5):1330-2. PubMed ID: 9574699 [TBL] [Abstract][Full Text] [Related]
4. Antifungal susceptibility testing using the E test: comparison with the broth macrodilution technique. Chen SC; O'Donnell ML; Gordon S; Gilbert GL J Antimicrob Chemother; 1996 Feb; 37(2):265-73. PubMed ID: 8707736 [TBL] [Abstract][Full Text] [Related]
5. In vitro antifungal susceptibility of Candida. Chakrabarti A; Ghosh A; Kanta A; Kumar P Indian J Med Res; 1995 Jul; 102():13-9. PubMed ID: 7558204 [TBL] [Abstract][Full Text] [Related]
6. Commercial systems for fluconazole susceptibility testing of yeasts: comparison with the broth microdilution method. Posteraro B; Romano L; Sanguinetti M; Masucci L; Morace G; Fadda G Diagn Microbiol Infect Dis; 2000 Sep; 38(1):29-36. PubMed ID: 11025181 [TBL] [Abstract][Full Text] [Related]
7. In-vitro resistance to azoles associated with mitochondrial DNA deficiency in Candida glabrata. Defontaine A; Bouchara JP; Declerk P; Planchenault C; Chabasse D; Hallet JN J Med Microbiol; 1999 Jul; 48(7):663-670. PubMed ID: 10403417 [TBL] [Abstract][Full Text] [Related]
8. Comparison of broth dilution and semisolid agar dilution for in vitro susceptibility testing of Cryptococcus neoformans. Del Poeta M; Barchiesi F; Morbiducci V; Arzeni D; Marinucci G; Ancarani F; Scalise G J Chemother; 1994 Jun; 6(3):173-6. PubMed ID: 7983499 [TBL] [Abstract][Full Text] [Related]
9. Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms. Espinel-Ingroff A; Pfaller M; Messer SA; Knapp CC; Killian S; Norris HA; Ghannoum MA J Clin Microbiol; 1999 Mar; 37(3):591-5. PubMed ID: 9986817 [TBL] [Abstract][Full Text] [Related]
10. In vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformans. Pfaller MA; Messer SA; Hollis RJ; Jones RN Antimicrob Agents Chemother; 2001 Oct; 45(10):2862-4. PubMed ID: 11557481 [TBL] [Abstract][Full Text] [Related]
11. [In vitro pharmacological study of fluconazole. Evaluation of an antifungal assay]. Duval F; Lavarde V Pathol Biol (Paris); 1993 May; 41(5):469-73. PubMed ID: 8414680 [TBL] [Abstract][Full Text] [Related]
12. In Vitro Activities of Novel Azole Compounds ATTAF-1 and ATTAF-2 against Fluconazole-Susceptible and -Resistant Isolates of Candida Species. Fakhim H; Emami S; Vaezi A; Hashemi SM; Faeli L; Diba K; Dannaoui E; Badali H Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795371 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Etest method for determining fluconazole susceptibilities of 402 clinical yeast isolates by using three different agar media. Pfaller MA; Messer SA; Karlsson A; Bolmström A J Clin Microbiol; 1998 Sep; 36(9):2586-9. PubMed ID: 9705397 [TBL] [Abstract][Full Text] [Related]
14. Comparison of three methods for testing azole susceptibilities of Candida albicans strains isolated sequentially from oral cavities of AIDS patients. Tortorano AM; Viviani MA; Barchiesi F; Arzeni D; Rigoni AL; Cogliati M; Compagnucci P; Scalise G J Clin Microbiol; 1998 Jun; 36(6):1578-83. PubMed ID: 9620380 [TBL] [Abstract][Full Text] [Related]
15. Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy. Warnock DW; Johnson EM; Rogers TR J Antimicrob Chemother; 1998 Sep; 42(3):321-31. PubMed ID: 9786472 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the in vitro activities of the echinocandin LY303366, the pneumocandin MK-0991, and fluconazole against Candida species and Cryptococcus neoformans. Krishnarao TV; Galgiani JN Antimicrob Agents Chemother; 1997 Sep; 41(9):1957-60. PubMed ID: 9303393 [TBL] [Abstract][Full Text] [Related]
17. Comparison of fluconazole minimum inhibitory concentrations in three different formulations of RPMI-1640. Espinel-Ingroff A; Steele-Moore L Diagn Microbiol Infect Dis; 1994 Oct; 20(2):87-91. PubMed ID: 7867310 [TBL] [Abstract][Full Text] [Related]
18. Modified colorimetric assay for susceptibility testing of azole antifungal drugs against Candida species. Chen J; Wan Z; Li R J Clin Microbiol; 2004 Apr; 42(4):1790-3. PubMed ID: 15071052 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of 80% inhibition standards for the determination of fluconazole minimum inhibitory concentrations in three laboratories. Espinel-Ingroff A; Steele-Moore L; Galgiani JN Diagn Microbiol Infect Dis; 1994 Oct; 20(2):81-6. PubMed ID: 7867309 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the Etest and microdilution method for antifungal susceptibility testing of Cryptococcus neoformans to four antifungal agents. Aller AI; Martín-Mazuelos E; Gutiérrez MJ; Bernal S; Chávez M; Recio FJ J Antimicrob Chemother; 2000 Dec; 46(6):997-1000. PubMed ID: 11102421 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]